Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance - Impact on Outcome

This study has been completed.
Sponsor:
Information provided by:
University of Leipzig
ClinicalTrials.gov Identifier:
NCT00952224
First received: August 3, 2009
Last updated: August 4, 2009
Last verified: August 2009

August 3, 2009
August 4, 2009
November 2006
May 2008   (final data collection date for primary outcome measure)
Major adverse cardiac events [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00952224 on ClinicalTrials.gov Archive Site
Mortality [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance - Impact on Outcome
Prognostic Significance and Determinants of Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance in Acute Reperfused Myocardial Infarction

In acute myocardial infarction cardiovascular magnetic resonance imaging can retrospectively detect the myocardium at risk and the irreversible injury. This allows for quantifying the extent of salvaged myocardium after reperfusion as a potential strong end point for clinical trials and outcome. The aim of the present study is to determine the prognostic significance and determinants of myocardial salvage assessed by CMR in reperfused ST-elevation myocardial infarction (STEMI).

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Cohort of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

ST-Elevation Myocardial Infarction
Other: magnetic resonance imaging
magnetic resonance imaging is used for prognosis assessment
Acute myocardial infarction patients
Patients undergoing primary percutaneous coronary intervention in ST-elevation myocardial infarction plus magnetic resonance imaging
Intervention: Other: magnetic resonance imaging

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
267
March 2009
May 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • ST-elevation myocardial infarction < 12 hours
  • primary percutaneous coronary intervention

Exclusion Criteria:

  • previous myocardial infarction
  • prior fibrinolysis
  • contraindications to CMR at study entry (such as implanted pacemakers, defibrillators, claustrophobia or metallic intracranial implants)
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT00952224
Leipzig MR 1
No
Not Provided
University of Leipzig
Not Provided
Principal Investigator: Ingo Eitel, MD University of Leipzig
Study Director: Holger Thiele, MD University of Leipzig
University of Leipzig
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP